ST. CHARLES MED CTR-REDMOND — History
CCN 380040 | 2-year financial timeline | COVID resilience: 58/100
🛡️ Public data only — no PHI permitted on this instance.
$99M
Latest Revenue (FY2021)
+23.3%
Revenue CAGR (2yr)
12.4%
Financial Timeline
| Metric | FY2020 | FY2021 | YoY (Latest) | CAGR |
|---|---|---|---|---|
| Net Patient Revenue | $80M | $99M | +23.3% | +23.3% |
| Operating Expenses | $67M | $87M | +29.7% | +29.7% |
| Operating Margin | 16.7% | 12.4% | -25.7% | -25.7% |
| Net Income | $13M | $12M | -8.4% | -8.4% |
| Licensed Beds | 36 | 36 | +0.0% | +0.0% |
| Total Patient Days | 7,862 | 13,377 | +70.1% | +70.1% |
| Medicare Day % | 41% | 39% | -3.4% | -3.4% |
| Medicaid Day % | 18% | 5% | -73.8% | -73.8% |
COVID Impact & Recovery
Resilience Score: 58/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2021: +23.3% ($80M → $99M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+23.3%
This Hospital
+13.0%
State Avg
Latest Margin
12.4%
This Hospital
-2.3%
State Avg
Projections (FY2022-2024)
Extrapolated from 2-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2022 (proj) | $118M | 8.1% |
| FY2023 (proj) | $137M | 3.8% |
| FY2024 (proj) | $156M | -0.5% |